🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquarePCOS and GLP-1 agonists — my results so far Page 3

PCOS and GLP-1 agonists — my results so far

ingrid_STO Sun, Mar 16, 2025 at 6:04 AM 29 replies 1,996 viewsPage 3 of 6
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 17, 2025 at 9:48 PM#11
EndoResFellow said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

22 22Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 19 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Mar 18, 2025 at 3:37 AM#12
VanRx_Mike said:
No disagreement, though the timescale matters more than the mechanism here.

This is exactly what I could not find anywhere else. Sending this to two other people who asked me the same thing last week.

Last edited: Mar 18, 2025 at 5:37 AM
21 21emily_PDX, Dr.SleepRoch, laura_annarbor and 18 others
Reply Quote Save Share Report
WendyG_ATL
Member
1,023
5,678
Apr 2024
Georgia
Mar 18, 2025 at 9:26 AM#13
EndoResFellow said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

20 20traveltech_sara, AttorneyGrant, DebRD_ATL and 17 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Mar 18, 2025 at 3:15 PM#14

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

19 19bri_stats, pete_manc_UK, anna.melb_AU and 16 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 18, 2025 at 9:04 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Report rather than reply if it drifts again.

18 18PurityPaulOR, MaxMetOK, MounjBrad and 15 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register